{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:36:20Z","timestamp":1787315780537,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      A dysfunction of NADH dehydrogenase, the mitochondrial Complex I (CI), associated with the development of left ventricular hypertrophy (LVH) in previous experimental studies. A deficiency of Ndufc2 (subunit of CI) impairs CI activity causing severe mitochondrial dysfunction. The T allele at\n                      <jats:italic>NDUFC2<\/jats:italic>\n                      \/rs11237379 variant associates with reduced gene expression and impaired mitochondrial function. The present study tested the association of both\n                      <jats:italic>NDUFC2<\/jats:italic>\n                      \/rs11237379 and NDUFC2\/rs641836 variants with LVH in hypertensive patients. In vitro studies explored the impact of reduced Ndufc2 expression in isolated cardiomyocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two-hundred-forty-six subjects (147 male, 59.7%), with a mean age of 59\u2009\u00b1\u200915 years, were included for the genetic association analysis.\n                      <jats:italic>Ndufc2<\/jats:italic>\n                      silencing was performed in both H9c2 and rat primary cardiomyocytes to explore the hypertrophy development and the underlying signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The TT genotype at\n                      <jats:italic>NDUFC2\/<\/jats:italic>\n                      rs11237379 associated with significantly reduced gene expression. Multivariate analysis revealed that patients carrying this genotype showed significant differences for septal thickness (p\u2009=\u20090.07), posterior wall thickness (p\u2009=\u20090.008), RWT (p\u2009=\u20090.021), LV mass\/BSA (p\u2009=\u20090.03), compared to subjects carrying either CC or CT genotypes. Patients carrying the A allele at\n                      <jats:italic>NDUFC2\/<\/jats:italic>\n                      rs641836 showed significant differences for septal thickness (p\u2009=\u20090.017), posterior wall thickness (p\u2009=\u20090.011), LV mass (p\u2009=\u20090.003), LV mass\/BSA (p\u2009=\u20090.002) and LV mass\/height\n                      <jats:sup>2.7<\/jats:sup>\n                      (p\u2009=\u20090.010) after adjustment for covariates.\n                      <jats:italic>In-vitro<\/jats:italic>\n                      , the Ndufc2 deficiency-dependent mitochondrial dysfunction caused cardiomyocyte hypertrophy, pointing to SIRT3-AMPK-AKT-MnSOD as a major underlying signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We demonstrated for the first time a significant association of\n                      <jats:italic>NDUFC2<\/jats:italic>\n                      variants with LVH in human hypertension and highlight a key role of Ndufc2 deficiency-dependent CI mitochondrial dysfunction on increased susceptibility to cardiac hypertrophy development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-023-00701-x","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T07:02:41Z","timestamp":1691564561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension"],"prefix":"10.1186","volume":"29","author":[{"given":"Giovanna","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cotugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Marchitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Stanzione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Palmerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Scioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Frati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Sciarretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-7368","authenticated-orcid":false,"given":"Speranza","family":"Rubattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"701_CR1","doi-asserted-by":"crossref","unstructured":"Chouchani ET, Methner C, Buonincontri G, Hu CH, Logan A, Sawiak SJ, Murphy MP, Krieg T. Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy. PLoS ONE. 2014;9: e94157.","DOI":"10.1371\/journal.pone.0094157"},{"key":"701_CR2","first-page":"579","volume":"97","author":"M Forte","year":"2019","unstructured":"Forte M, Palmerio S, Bianchi F, Volpe M, Rubattu S. Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions. J Mol Med (Berl). 2019;97:579\u201391.","journal-title":"J Mol Med (Berl)"},{"key":"701_CR3","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1080\/15548627.2019.1687215","volume":"16","author":"M Forte","year":"2020","unstructured":"Forte M, Bianchi F, Cotugno M, Marchitti S, De Falco E, Raffa S, Stanzione R, Di Nonno F, Chimenti I, Palmerio S, Pagano F, Petrozza V, Micaloni A, Madonna M, Relucenti M, Torrisi MR, Frati G, Volpe M, Rubattu S, Sciarretta S. Pharmacological restoration of autophagy reduces hypertension-related stroke occurrence. Autophagy. 2020;16:1468\u201381.","journal-title":"Autophagy"},{"key":"701_CR4","doi-asserted-by":"crossref","unstructured":"Forte M, Marchitti S, Di Nonno F, Stanzione R, Schirone L, Cotugno M, Bianchi F, Schiavon S, Raffa S, Ranieri D, Fioriniello S, Della Ragione F, Torrisi MR, Carnevale R, Valenti V, Versaci F, Frati G, Vecchione C, Volpe M, Rubattu S, Sciarretta S. NPPA\/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart. Autophagy. 2022.","DOI":"10.1080\/15548627.2022.2115675"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"921244","DOI":"10.3389\/fcvm.2022.921244","volume":"9","author":"G Gallo","year":"2022","unstructured":"Gallo G, Migliarino S, Cotugno M, Stanzione R, Burocchi S, Bianchi F, Marchitti S, Autore C, Volpe M, Rubattu S. Impact of a NDUFC2 variant on the occurrence of Acute Coronary Syndromes. Front Cardiovasc Med. 2022;9:921244.","journal-title":"Front Cardiovasc Med"},{"key":"701_CR6","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/gbe\/evu208","volume":"6","author":"M Gershoni","year":"2014","unstructured":"Gershoni M, Levin L, Ovadia O, Toiw Y, Shani N, Dadon S, Barzilai N, Bergman A, Atzmon G, Wainstein J, Tsur A, Nijtmans L, Glaser B, Mishmar D. Disrupting mitochondrial-nuclear coevolution affects OXPHOS complex I integrity and impacts human health. Genome Biol Evol. 2014;6:2665\u201380.","journal-title":"Genome Biol Evol"},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","volume":"123","author":"AE Kane","year":"2018","unstructured":"Kane AE, Sinclair DA. Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases. Circ Res. 2018;123:868\u201385.","journal-title":"Circ Res"},{"key":"701_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","volume":"43","author":"F Kuwahara","year":"2004","unstructured":"Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension. 2004;43:739\u201345.","journal-title":"Hypertension"},{"key":"701_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1\u201339. e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"701_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470\u20139.","journal-title":"Circulation"},{"key":"701_CR11","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1021\/pr801059u","volume":"8","author":"C Meng","year":"2009","unstructured":"Meng C, Jin X, Xia L, Shen SM, Wang XL, Cai J, Chen GQ, Wang LS, Fang NY. Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats. J Proteome Res. 2009;8:2463\u201375.","journal-title":"J Proteome Res"},{"key":"701_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"701_CR13","doi-asserted-by":"crossref","unstructured":"Ni Y, Hagras MA, Konstantopoulou V, Mayr JA, Stuchebrukhov AA, Meierhofer D. Mutations in NDUFS1 cause metabolic reprogramming and disruption of the Electron transfer. Cells. 2019;8.","DOI":"10.3390\/cells8101149"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","volume":"51","author":"JN Peoples","year":"2019","unstructured":"Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med. 2019;51:1\u201313.","journal-title":"Exp Mol Med"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cvr\/cvq250","volume":"88","author":"VB Pillai","year":"2010","unstructured":"Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP. Mitochondrial SIRT3 and heart disease. Cardiovasc Res. 2010a;88:250\u20136.","journal-title":"Cardiovasc Res"},{"key":"701_CR16","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","volume":"285","author":"VB Pillai","year":"2010","unstructured":"Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem. 2010b;285:3133\u201344.","journal-title":"J Biol Chem"},{"key":"701_CR17","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1093\/hmg\/ddx333","volume":"26","author":"S Raffa","year":"2017","unstructured":"Raffa S, Scrofani C, Valente S, Micaloni A, Forte M, Bianchi F, Coluccia R, Geurts AM, Sciarretta S, Volpe M, Torrisi MR, Rubattu S. In vitro characterization of mitochondrial function and structure in rat and human cells with a deficiency of the NADH: ubiquinone oxidoreductase Ndufc2 subunit. Hum Mol Genet. 2017;26:4541\u201355.","journal-title":"Hum Mol Genet"},{"key":"701_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijcard.2019.02.027","volume":"286","author":"S Raffa","year":"2019","unstructured":"Raffa S, Chin XLD, Stanzione R, Forte M, Bianchi F, Cotugno M, Marchitti S, Micaloni A, Gallo G, Schirone L, Tocci G, Violini R, Torrisi MR, Volpe M, Rubattu S. The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome. Int J Cardiol. 2019;286:127\u201333.","journal-title":"Int J Cardiol"},{"key":"701_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","volume":"55","author":"MG Rosca","year":"2013","unstructured":"Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013;55:31\u201341.","journal-title":"J Mol Cell Cardiol"},{"key":"701_CR20","doi-asserted-by":"crossref","unstructured":"Rubattu S, Di Castro S, Schulz H, Geurts AM, Cotugno M, Bianchi F, Maatz H, Hummel O, Falak S, Stanzione R, Marchitti S, Scarpino S, Giusti B, Kura A, Gensini GF, Peyvandi F, Mannucci PM, Rasura M, Sciarretta S, Dwinell MR, Hubner N, Volpe M. Ndufc2 gene inhibition is Associated with mitochondrial dysfunction and increased stroke susceptibility in an animal model of Complex Human Disease. J Am Heart Assoc. 2016;5.","DOI":"10.1161\/JAHA.115.002701"},{"key":"701_CR21","first-page":"2758","volume":"119","author":"NR Sundaresan","year":"2009","unstructured":"Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest. 2009;119:2758\u201371.","journal-title":"J Clin Invest"},{"key":"701_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.carpath.2013.11.002","volume":"23","author":"Y Tang","year":"2014","unstructured":"Tang Y, Mi C, Liu J, Gao F, Long J. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat. Cardiovasc Pathol. 2014;23:101\u20136.","journal-title":"Cardiovasc Pathol"},{"key":"701_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11897-012-0109-5","volume":"9","author":"L van Heerebeek","year":"2012","unstructured":"van Heerebeek L, Franssen CP, Hamdani N, Verheugt FW, Somsen GA, Paulus WJ. Molecular and cellular basis for diastolic dysfunction. Curr Heart Fail Rep. 2012;9:293\u2013302.","journal-title":"Curr Heart Fail Rep"},{"key":"701_CR24","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Group ESCSD. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"701_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/01.RES.84.6.722","volume":"84","author":"W Zhang","year":"1999","unstructured":"Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res. 1999;84:722\u20138.","journal-title":"Circ Res"},{"key":"701_CR26","doi-asserted-by":"publisher","first-page":"5545261","DOI":"10.1155\/2021\/5545261","volume":"2021","author":"R Zou","year":"2021","unstructured":"Zou R, Tao J, Qiu J, Shi W, Zou M, Chen W, Li W, Zhou N, Wang S, Ma L, Chen X. Ndufs1 Deficiency aggravates the mitochondrial membrane potential dysfunction in pressure Overload-Induced myocardial hypertrophy. Oxid Med Cell Longev. 2021;2021:5545261.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00701-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T18:05:29Z","timestamp":1700330729000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00701-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00701-x","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the ethical standards of the Declaration of Helsinki and was reviewed and approved by the institutional ethics committee of our center. Written informed consent was obtained from all included participants. Animal experiments for the isolation of neonatal cardiomyocytes were performed in accordance with the European Commission guidelines (Dlg 2010\/63\/EU) and the protocol was approved by Italian Ministry of Health (protocol n.: 1086\/2020-PR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have contributed to, read, and approved the final version of this manuscript for submission and publication in the journal Molecular Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}